The effect of 5-bromo-2'-deoxyuridine (BrdUrd) and dibutyryl cyclic AMP (Bt2cAMP) on the expression of the placental isoenzyme of human alkaline phosphatase was examined in BeWo choriocarcinoma cells. By using a combination of specific immunoprecipitation and polyacrylamide-gel electrophoresis of cells labelled either metabolically with [35Slmethionine or cell-surface-labelled with 125I, both BrdUrd (5,ug/ml) and 1 mM-Bt2cAMP were shown to result in the enhanced accumulation of a specific protein. This protein has immunochemical identity and co-electrophoreses with placental alkaline phosphatase in two-dimensional gels. These results clearly demonstrate that the induction of placental alkaline phosphatase activity in choriocarcinoma cells treated with these agents is a consequence of the accumulation of specific enzyme protein rather than of altered catalytic activity.
The placental form of alkaline phosphatase (EC 3.1.3.1) is a structurally unique protein whose normal expression is limited to the placenta (McKenna et al., 1979; Badger & Sussman, 1976) . It is, however, observed with greater than random frequency in the serum of patients with both trophoblastic and non-trophoblastic tumours (Fishman et al., 1968) , and it has been clearly demonstrated that the tumour isoenzyme is structurally identical with placental alkaline phosphatase (Greene & Sussman, 1973; Wada et al., 1979a) . The molecular events governing the re-expression of this placental gene may be related to the process of neoplastic development.
It is well documented that alkaline phosphatase activity can be induced 10-20-fold in cultured cells in response to a wide variety of perturbants (Ghosh et al., 1972; Singer & Herz, 1978; Goz & Walker, 1978; Hamilton et al., 1979a) . However, the molecular mechanisms through which this induction occurs remain unclear. Work (Hamilton et al., 1979a) . By using a radioimmunoassay for that enzyme, it was also observed that placental-alkaline-phosphatase-related antigen increased in a parallel fashion with enzyme activity, suggesting that the enhanced activity results from the enhanced accumulation of enzyme protein.
Others have reported that the induction of placental alkaline phosphatase in HeLa cells treated with cortisol, BrdUrd or iododeoxyuridine is a consequence of altered kinetic properties of the enzyme and not of new enzyme synthesis (Ghosh et al., 1972; Goz & Walker, 1978; Morrow et al., 1979) . In order to evaluate this question further, we have studied choriocarcinoma cells treated with BrdUrd or Bt2cAMP by using two independent radiolabelling techniques. The results clearly demonstrate that a protein showing immunochemical and physical identity with placental alkaline phosphatase accumulates at a rate significantly greater than a group of other unaffected placental cell-surface proteins.
Materials and methods

Cell culture
BeWo cells were grown as previously described (Hamilton et al., 1979a (Gibco, Grand Island, NY, U.S.A.) and then scraped with a rubber policeman into 1 ml of TNM buffer (20mM-Tris/HCl, pH7.4, 150mM-NaCl, 2mM-MgCl2) and extracted with 1% Triton X-100 for 10min at 0°C. The detergent extracts were then centrifuged at 140OOOg for 60min. The supernatant was used for immunoprecipitation as described below. Total incorporated radioisotope was determined by trichloroacetic acid precipitation, filtration on Whatman (Maidstone, Kent, U.K.) GF/C filters, and liquid-scintillation counting in toluene with Omnifluor (New England Nuclear).
Cell-surface labelling by lactoperoxidase-catalysed iodination
Cell-surface iodination was performed on T-75 cultures grown for 96 h in the presence or absence of drugs. The method for lactoperoxidase-catalysed iodination was as described previously Hamilton et al., 1979b) . Briefly, contents of one T-75 flask were labelled with 1 ml of phosphate-buffered saline (150mM-NaCl/10 mM-sodium phosphate, pH 7.4) containing 100,ug of lactoperoxidase (Sigma Chemical Co., St. Louis, MO, U.S.A.), 100-200#uCi of carrier-free Na125I (New England Nuclear) and two 10,ul batches of 250,M-H202 added at 5 min intervals. After a 10min labelling period, 50,1 of 0.5 M-NaCl was added and the excess free iodine was washed away with phosphate-buffered saline. Labelled cells were then harvested, extracted and centrifuged as described for [35Slmethionine labelling.
Preparation ofplacental membrane vesicles
Human placentas were obtained within 20min of delivery, and the brush-border membrane fraction was isolated by the method of Smith et al. (1977) . Vesicles were labelled with 125I by using lactoperoxidase as described above.
Immunoprecipitation and gel electrophoresis
Triton X-100 extracts from 35S-or 125I-labelled cells were immunoprecipitated with a goat anti-(human placental brush-border protein) antiserum, which has been thoroughly described elsewhere Hamilton et al., 1979b) . In some instances, extracts were precipitated by using goat antiserum raised against homogeneous placental alkaline phosphatase as described by Sussman et al. (1968) . Extracts were first pretreated with 10,ul of non-immune goat serum and 100l1 of a 10% (w/v) suspension of heat-killed formalin-fixed Staphylococcus aureus (Cowen strain I) (Kessler, 1975) . Pretreated samples were then specifically precipitated with 10-20,1 of anti-(human placental brushborder protein) antiserum or anti-(placental alkaline phosphatase) serum at 0°C, followed by adsorption to S. aureus as described above. The immune precipitates were washed thoroughly in NET buffer (l5OmM-NaCl, 5mM-EDTA, 50mM-Tris/HCl, pH7.4, 0.5% Triton X-100) containing ovalbumin (1 mg/ml; Sigma) and 5 mM-NaI or 1 mM-methionine. The immune complexes were eluted in 4% SDS/0.25M-Tris/HCI (pH6.8)/10% (v/v) glycerol/ 5% (v/v) fl-mercaptoethanol and boiled for 2min before analysis by 8%-polyacrylamide-gel electrophoresis as described by Laemmli (1970) . For two-dimensional electrophoretic analysis, eluted samples were diluted 10-fold with 5-mM-sodium phosphate (pH8.0)/2% Triton X-100/8 M-urea and concentrated to 100,u1 in an Amicon (Lexington, MA, U.S.A.) A25 mini-concentrator. These samples were then analysed by two-dimensional polyacrylamide-gel electrophoresis as described by O'Farrell (1975) and modified by Wada et al. (1977) . Gels were fixed in 7% (v/v) acetic acid/50% (v/v) methanol overnight.
[35S]Methionine-containing gels were impregnated with dimethyl sulphoxide/2,5-diphenyloxazole for autofluorography (Laskey & Mills, 1975) . Gels were dried under vacuum and exposed by using pre-flashed Kodak (Rochester, NY, U.S.A.) RP X-Omat X-ray film at -760C for 1-4 days. Exposure was enhanced by Dupont (Wilmington, DE, U.S.A.) 'Lightening Plus' intensifying screens. For quantification of radioautographs, films were scanned at 550nm in a Transidyne (Ann Arbor, MI, U.S.A.) scanning densitometer.
Alkaline phosphatase activity was measured as described by Bessey et al. (1946) , and protein was determined by the method of Lowry et al. (1951) .
Results
In order to quantify the relative amount of alkaline phosphatase protein accumulated in cells treated with BrdUrd or Bt2cAMP, we have radiolabelled control and experimental cultures by two independent techniques, either metabolically with [35Slmethionine or enzymically by using cell-surfacespecific lactoperoxidase-catalysed iodination. In Alkaline phosphatase in choriocarcinoma cells addition, we have analysed the radiolabelled extracts by polyacrylamide-gel electrophoresis after immunoprecipitation with antisera directed either specifically against placental alkaline phosphatase or against a set of placental brush-border membrane glycoproteins including placental alkaline phosphatase. The first antiserum provides an immunochemical identification, and the second allows quantification of the amount of incorporated radiolabel relative to a set of similar membrane proteins which appear to be unaffected by the treatments involved. Fig. 1 (a) is a schematic representation of a two-dimensional electrophoretogram of human placental brush-border glycoproteins which react with anti-(placental brush-border) serum; 13 individual subunits have been resolved and described Fig. l(a) .
Vol. 198 (Wada et al., 1977 ; Hamilton et al., 1979b) . Fig. l(b) shows the same subunits immunoprecipitated and analysed by one-dimensional SDS/ polyacrylamide-gel electrophoresis. Eight major bands can be seen and their probable correspondence to the various numbered subunits is indicated. The subunit molecular weights (Mr) and isoelectric points (pl) for each component are detailed in Table 1 . The tissue distribution of each antigen is indicated in Fig. l(a) . Filled spots are components ubiquitously expressed on all human cells examined to date, including adult liver, kidney ) and a variety of phenotypically distinct cultured cells (Hamilton et al., 1979b) . Open spots represent those subunits that are differentially expressed among the various tissues and cell types examined. Subunit 23 has been previously identified as the placental isoenzyme of alkaline phosphatase on the basis of co-electrophoresis in two-dimensional gels (Wada et al., 1977) . Eleven (2, 7, 7a, 6b, 8, 9, 15a, 15b, 23, 21, 24 ) of these components have been identified in BeWo choriocarcinoma cells (Hamilton et al., 1979a,b) . Fig. 2 shows gels of BeWo cells treated by BrdUrd or Bt2cAMP which have been labelled by lactoperoxidase-catalysed cell-surface iodination. Lane 1 is from a control culture and lanes 2 and 3 are from Bt2cAMP-and BrdUrd-treated cells respectively, all immunoprecipitated with anti-(human placental brush-border protein) antiserum. The enhancement of a band at M, -64000 is clearly 125I. The appearance of a series of spots at Mr 64000 and pl 6.2-6.4 in induced cells provides confirmation of the identity of the inducible protein identified in Fig. 2 (lanes 2, 3, 5 and 6) as placental alkaline phosphatase. It is noteworthy that spots 21 and 24 also show a relative increase in density in the two-dimensional gels of cells treated with BrdUrd. However, these subunits are apparently not related to alkaline phosphatase because they are present in cells which do not express detectable enzyme activities. Most of the other spots do not appear to have changed in density. However, quantification of Alkaline phosphatase in choriocarcinoma cells spot intensity in two-dimensional gels is an unreliable procedure. Fig. 4 molecular-weight components can be seen than in lanes 7 and 8, owing to longer exposure time and greater radioactivity in the sample applied. Nine major bands are resolved by scanning the radioautographs at 550 nm, and these are indicated by the numbering in lane 8. Comparison of control gels (lanes 5 and 7) with those from drug-treated cultures (lanes 6 and 8) shows the defined complement of glycoproteins to be present in apparently similar quantities, except for a band of Mr 64000, which is considerably enhanced. This induced band comigrates with homogeneous placental alkaline phosphatase. Table 2 gives the results of quantification of the gels shown in Fig. 4 by scanning the radioautographs at 550nm and integrating each band. This analysis resolves a total of eight major bands, which are indicated by numbers in Fig. 4 (lane 8) . The amount of each component relative to the other components in the gel was quantified by determining the ratio of individual peak size to peak sizes for two other bands from the same gel (nos. 2 and 4), which appeared to be relatively constant between the matched control and drug-treated cells. The data are given as percentages of the ratios in control cells. BrdUrd results in a minor decrease (<50%) in the relative amount of component 1 and a major in- Table 2 . Relative amounts ofplacental glycoproteins in BrdUrd-or Bt2cAMP-treated choriocarcinoma cells Gels from Fig. 4 were scanned at 550nm and the relative intensity of each band was estimated by integrating each peak. Bands 2 and 4 showed constant values between matched control and experimental samples. crease in amount of placental alkaline phosphatase (>700%). Bt2cAMP caused a small decrease in components 1 (-40%) and 8 (-60%), and again a major increase in placental alkaline phosphatase (250%). Otherwise, all components showed nearly identical quantities in control and drug-treated cells. Alkaline phosphatase enzyme activity in control cultures was approx. 0.05 unit/mg of protein, and BrdUrd and Bt2cAMP treatment increased this value to 0.38 and 0.29 unit/mg respectively. The relative enhancement of enzyme activity (5-10-fold) agrees within less than a factor of 2, with the determination from the densitometric data for [35S]methionine-labelled proteins (Fig. 4) presented in Table 2 .
Discussion
BeWo cells, a human choriocarcinoma-derived cell line, express both the placental and liver isoenzymes of alkaline phosphatase (Hamilton et al., 1979a) , each of which is structurally distinct (Badger & Sussman, 1976) . Only the placental isoenzyme is specifically induced by BrdUrd or Bt2cAMP, demonstrating the independent regulation of separate alkaline phosphatase genes (Hamilton et al., 1979a) . The present paper provides evidence for internal labelling of the molecule, to show a quantitative increase in this molecule in response to these perturbants. It also describes the effect of these perturbants on the expression of placental alkaline phosphatase relative to a defined set of cell-surface glycoprotein antigens, which include placental alkaline phosphatase, and which are expressed by the BeWo cell line. This set of membrane antigens provides an internal standard against which a determination of the relative quantity of specific enzyme protein can be made. Quantitative examination of this set of placental membrane glycoproteins by SDS/polyacrylamidegel electrophoresis in 125I1 or [35Slmethionine-labelled cells showed a specific 3-8-fold enhancement of the accumulation of one subunit with an apparent M, of approx. 64000 after treatment with either BrdUrd or Bt2cAMP. We have determined this component to be the subunit of the placental isoenzyme of alkalline phosphatase on the basis of its immunochemical reactivity with specific antiserum and its electrophoretic mobility in both oneand two-dimensional polyacrylamide-gel-electrophoretic systems. The use of two technically independent methods for radioactive labelling of cellular protein indicates that the increased labelling of placental alkaline phosphatase does not result from differential labelling efficiency as a consequence of drug treatment.
The enhancement of alkaline phosphatase activity in cultured human cells by various perturbants has been previously documnented both in our laboratory and elsewhere (Ghosh et al., 1972; Singer & Herz, 1978; Goz & Walker, 1978; Hamilton et al., 1979a; Morrow et al., 1979) . Nevertheless, these earlier studies have not entirely resolved the question of whether the enhanced activity results from an increased quantity of specific enzyme protein. Ghosh et al. (1972) have reported that the induction of alkaline phosphatase in HeLa cells with cortisol results from a change in the kinetic properties of the enzyme, with no new enzyme synthesis required, and others have suggested that this may be the case with BrdUrd or iododeoxyuridine induction of HeLa cells (Morrow et al., 1979; Goz & Walker, 1978) . In contrast, Hamilton et al. (1979a) The quantitative extent of induction of band 6 (see Fig. 4 , lanes 6 and 8, and Table 2 ) and of alkaline phosphatase activity agree closely, but the calculated enhancement of band-6 protein consistently underestimates the measured enhancement of alkaline phosphatase activity. These differences probably result from the methodology employed in quantifying band-6 protein by using autofluorography.
Because the labelling period with [35S]methionine (48 h) could be long relative to the turnover time for alkaline phosphatase, it cannot be determined whether the increased accumulation of placental alkaline phosphatase protein results from altered rates of enzyme synthesis or degradation.
Although the synthesis of placental alkaline phosphatase appears to be highly specific to the placenta under normal conditions (McKenna et al., 1979) , its re-expression in both trophoblastic and non-trophoblastic neoplasia has been clearly documented (Fishman et al., 1968; Sussman, 1978) . The high degree of specificity of induction for the placental isoenzyme compared with the other trophoblast cell-surface glycoprotein antigens demonstrated in the current study, and the frequency of its induction under a variety of conditions in other cell types, may be related to the frequent re-expression of placental alkaline phosphatase in malignancy. Furthermore, because placental alkaline phosphatase is representative of the differentiated trophoblast in the term placenta, the effect of BrdUrd and Bt2cAMP observed in choriocarcinoma cells, which represent a less differentiated form of the cell, may represent limited biochemical differentiation of this cell type. The molecular mechanisms involved in this process require further investigation.
